 | Up a level |
Jump to: Journal Article
Number of items: 1.
Journal Article
Sehn, Laurie Helen, Scholz, Christian W., Luminari, Stefano 
ORCID: 0000-0001-8446-2285, Salar, Antonio, Wahlin, Bjorn E., Gopal, Ajay K., Bonnet, Christophe Marc, Paneesha, Shankara, Manzke, Oliver, Seguy, Francis, Li, Di and Huebel, Kai
(2021).
A phase 3 study to evaluate the efficacy and safety of tafasitamab plus lenalidomide and rituximab versus placebo plus lenalidomide and rituximab in patients with relapsed/refractory (R/R) follicular lymphoma (FL) or marginal zone lymphoma (MZL).
J. Clin. Oncol., 39 (15).
PHILADELPHIA:
LIPPINCOTT WILLIAMS & WILKINS.
ISSN 1527-7755